{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T14:01:23Z","timestamp":1791640883163,"version":"4.3.4"},"reference-count":97,"publisher":"Wiley","issue":"1","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd003198","type":"journal-article","created":{"date-parts":[[2003,11,20]],"date-time":"2003-11-20T22:18:21Z","timestamp":1069366701000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Tryptophan and 5-Hydroxytryptophan for depression"],"prefix":"10.1002","volume":"2010","author":[{"given":"Kelly A","family":"Shaw","sequence":"first","affiliation":[{"name":"Public Health Unit; Menzies Research Institute; 2\/152 Macquarie Street Hobart Tasmania Australia 7000"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Turner","sequence":"additional","affiliation":[{"name":"University of Queensland; Department of Psychiatry; Department of Psychiatry Royal Brisbane Hospital Herston Queensland Australia 4006"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Del Mar","sequence":"additional","affiliation":[{"name":"Bond University; Faculty of Health Sciences and Medicine; University Pde Robina Gold Coast Queensland Australia 4229"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2002,1,21]]},"reference":[{"key":"10.1002\/14651858.CD003198-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1017\/S0033291700049047","article-title":"The treatment of depression in general practice: A comparison of L-tryptophan, amitriptyline, and a combination of L-Tryptophan and Amitriptyline with placebo","volume":"12","author":"Thomson","year":"1982","journal-title":"Psychological Medicine"},{"issue":"4","key":"10.1002\/14651858.CD003198-BIB0002|cit2","first-page":"34","article-title":"5-Hydroxytryptophan as antidepressant: The predictive value of the probenecid test","volume":"8","author":"Praag","year":"1972","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD003198-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/BF00422612","article-title":"A pilot study of the predictive value of the probenecid test in application of 5-Hydroxytryptophan as antidepressant","volume":"25","author":"Praag","year":"1972","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD003198-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000468207","article-title":"5-Hydroxytryptophan (5-HTP) and a MAOI (nialamide) in the treatment of depression. A double blind controlled study","volume":"11","author":"Alino","year":"1976","journal-title":"International Pharmacopsychiatry"},{"issue":"2","key":"10.1002\/14651858.CD003198-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/BF00346485","article-title":"The treatment of depression with L-5-Hydroxytryptophan versus imipramine. Results of two open and one double-blind study","volume":"224","author":"Angst","year":"1977","journal-title":"Archiv fuer Psychiatrie und Nervenkrankheiten"},{"issue":"6","key":"10.1002\/14651858.CD003198-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"525","DOI":"10.15288\/jsa.1989.50.525","article-title":"The efficacy of L-Tryptophan in the reduction of sleep disturbance and depressive state in alcoholic patients","volume":"50","author":"Asheychik","year":"1989","journal-title":"Journal of Studies on Alcohol"},{"issue":"2","key":"10.1002\/14651858.CD003198-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1159\/000468258","article-title":"Tryptophan and an MAOI (Nialamide) in the treatment of depression","volume":"6","author":"Ayuso Gutierrez","year":"1971","journal-title":"International Pharmacopsychiatry"},{"issue":"3","key":"10.1002\/14651858.CD003198-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/00004850-198707000-00008","article-title":"The Newcastle chronic depression study: Results of a treatment regime","volume":"2","author":"Barker","year":"1987","journal-title":"International Clinical Psychopharmacology"},{"issue":"4","key":"10.1002\/14651858.CD003198-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1001\/archpsyc.1994.03950040053007","article-title":"Tryptophan depletion in patients with obsessive-compulsive disorder who respond to serotonin reuptake inhibitors","volume":"51","author":"Barr","year":"1994","journal-title":"Archives of General Psychiatry"},{"issue":"11","key":"10.1002\/14651858.CD003198-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1001\/archpsyc.1992.01820110016002","article-title":"Neuroendocrine responses to m-chlorphenylpiperazine and L-tryptophan in bulimia","volume":"49","author":"Brewerton","year":"1992","journal-title":"Archives of General Psychiatry"},{"issue":"654","key":"10.1002\/14651858.CD003198-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S0140-6736(70)91096-2","article-title":"Sequential comparison of L-tryptophan with ECT in severe depression","volume":"1","author":"Carroll","year":"1970","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003198-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1136\/bmj.1.6124.1422-a","article-title":"Tryptophan dosage critical for its antidepressant effect","volume":"1","author":"Chouinard","year":"1978","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD003198-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1600-0447.1979.tb04482.x","article-title":"Tryptophan-nicotinamide, imipramine and their combination in depression. A controlled study","volume":"59","author":"Chouinard","year":"1979","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"5","key":"10.1002\/14651858.CD003198-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1177\/070674378002500507","article-title":"A placebo controlled evaluation of L-Tryptophan in depression in the elderly","volume":"25","author":"Cooper","year":"1980","journal-title":"Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie"},{"issue":"7656","key":"10.1002\/14651858.CD003198-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S0140-6736(70)92774-1","article-title":"L-tryptophan in depression","volume":"1","author":"Coppen","year":"1970","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003198-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1001\/archpsyc.1972.01750210042009","article-title":"The comparative antidepressant value of L-Tryptophan and Imipramine with and without attempted potentiation by lyothyronine","volume":"26","author":"Coppen","year":"1972","journal-title":"Archives of General Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD003198-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1001\/archpsyc.1972.01750210050010","article-title":"Thyroid function and the response to liothyronine in depression","volume":"26","author":"Whybrow","year":"1972","journal-title":"Archives of General Psychiatry"},{"issue":"7950","key":"10.1002\/14651858.CD003198-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S0140-6736(76)90185-9","article-title":"Treatment of unipolar depression","volume":"1","author":"Coppen","year":"1976","journal-title":"Lancet"},{"issue":"4","key":"10.1002\/14651858.CD003198-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1600-0447.1977.tb00232.x","article-title":"Evaluation of a combination of tryptophan and ECT in the treatment of depression II Biochemical analysis","volume":"56","author":"D'Elia","year":"1977","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"4","key":"10.1002\/14651858.CD003198-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1600-0447.1977.tb00231.x","article-title":"Evaluation of the combination of tryptophan and ECT in the treatment of depression I Clinical analysis","volume":"56","author":"d'Elia","year":"1977","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"3","key":"10.1002\/14651858.CD003198-BIB0021|cit21","first-page":"259","article-title":"Influence of tryptophan on memory functions in depressive patients treated with unilateral ECT","volume":"57","author":"d'Elia","year":"1978","journal-title":"Acta Psychiatrica Scandinavica 57[3], 259-68. 1978"},{"issue":"4","key":"10.1002\/14651858.CD003198-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1001\/archpsyc.1972.01750220074014","article-title":"Effect of L-Tryptophan on brain serotonin metabolism in depressed patients","volume":"26","author":"Dunner","year":"1972","journal-title":"Archives of General Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD003198-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1176\/ajp.132.2.180","article-title":"Affective disorder: studies with amine precursors","volume":"132","author":"Dunner","year":"1975","journal-title":"American Journal of Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD003198-BIB0024|cit24","first-page":"295","article-title":"L-Tryptophan in depression","volume":"11","author":"Farkas","year":"1976","journal-title":"Biological Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD003198-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0022-3956(69)90013-2","article-title":"Potentiation of a monoamine oxidase inhibitor by tryptophan","volume":"7","author":"Glassman","year":"1969","journal-title":"Journal of Psychiatry Research"},{"key":"10.1002\/14651858.CD003198-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1192\/bjp.137.3.233","article-title":"Prospective trial of L-Tryptophan in maternity blues","volume":"137","author":"Harris","year":"1980","journal-title":"British Journal of Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD003198-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1017\/S003329170001833X","article-title":"Comparative trial of L-Tryptophan and amitriptyline in depressive illness","volume":"6","author":"Herrington","year":"1976","journal-title":"Psychological Medicine"},{"issue":"4","key":"10.1002\/14651858.CD003198-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1007\/BF00435851","article-title":"Kinetics of L-Tryptophan in depressive patients: A possible correlation between the plasma concentrations of L-Tryptophan and some psychiatric rating scales","volume":"75","author":"Hoes","year":"1981","journal-title":"Psychopharmacology"},{"issue":"4","key":"10.1002\/14651858.CD003198-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/BF00435850","article-title":"The clinical significance of disordered renal excretion of xanthurenic acid in depressive patients","volume":"75","author":"Hoes","year":"1981","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD003198-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0165-0327(82)90022-2","article-title":"Lithium plus L-Tryptophan compared with amitriptyline in endogenous depression","volume":"4","author":"Honore","year":"1982","journal-title":"Journal of Affective Disorders"},{"issue":"1","key":"10.1002\/14651858.CD003198-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0165-0327(83)90038-1","article-title":"Tryptophan and tyrosine ratios to neutral amino acids in endogenous depression. Relation to antidepressant response to amitriptyline and lithium + L-tryptophan","volume":"5","author":"Moller","year":"1983","journal-title":"Journal of Affective Disorders"},{"issue":"12","key":"10.1002\/14651858.CD003198-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1001\/archpsyc.1987.01800240062009","article-title":"Neuroendocrine response to 5-hydroxytryptophan in seasonal affective disorder","volume":"44","author":"Jacobsen","year":"1987","journal-title":"Archives of General Psychiatry"},{"issue":"7941","key":"10.1002\/14651858.CD003198-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/S0140-6736(75)92151-0","article-title":"Tryptophan\/imipramine in depression","volume":"2","author":"Jensen","year":"1975","journal-title":"Lancet"},{"issue":"5","key":"10.1002\/14651858.CD003198-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1600-0447.1978.tb03576.x","article-title":"Addition of L-Tryptophan to electroconvulsive treatment in endogenous depression","volume":"58","author":"Kirkegaard","year":"1978","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1002\/14651858.CD003198-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1176\/ajp.121.4.379","article-title":"Further studies on one day treatment of depression with 5-HTP","volume":"121","author":"Kline","year":"1964","journal-title":"American Journal of Psychiatry"},{"issue":"7","key":"10.1002\/14651858.CD003198-BIB0036|cit36","first-page":"484","article-title":"Comparable therapeutic efficacy of tryptophan and imipramine: average therapeutic ratings versus 'true' equivalence. An important difference.","volume":"15","author":"Kline","year":"1973","journal-title":"Current Therapeutic Research"},{"issue":"4","key":"10.1002\/14651858.CD003198-BIB0037|cit37","first-page":"337","article-title":"Preliminary randomized double-blind placebo-controlled trial of tryptophan combined with fluoxetine to treat major depressive disorder: antidepressant and hypnotic effects","volume":"25","author":"Levitan","year":"2000","journal-title":"Journal of Psychiatry and Neuroscience"},{"issue":"3","key":"10.1002\/14651858.CD003198-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1600-0447.1979.tb00277.x","article-title":"Symptom reduction in depression after treatment with L-Tryptophan or imipramine. Item analysis of Hamilton rating scale for depression","volume":"60","author":"Lindberg","year":"1979","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"11","key":"10.1002\/14651858.CD003198-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1001\/archpsyc.1980.01780240093011","article-title":"Clomipramine and doxepin in depressive neurosis","volume":"37","author":"Linnoila","year":"1980","journal-title":"Archives of General Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD003198-BIB0040|cit40","first-page":"471","article-title":"Tryptophan and amitriptyline in the treatment of depression (double blind study)","volume":"1","author":"Ayuso Gutierrez","year":"1973","journal-title":"Actas Luso Espanolas de Neurologia Psiquiatria y Ciencias Afines"},{"key":"10.1002\/14651858.CD003198-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000467985","article-title":"Tryptophan and amitriptyline in the treatment of depression: A double blind study","volume":"8","author":"Lopez Ibor Alino","year":"1973","journal-title":"International Pharmacopsychiatry"},{"issue":"4","key":"10.1002\/14651858.CD003198-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/0278-5846(95)00106-6","article-title":"Neural amino acid availability in two major psychiatric disorders","volume":"19","author":"Lucca","year":"1995","journal-title":"Progress in Neuro-Psychopharmacology & Biological Psychiatry"},{"issue":"7933","key":"10.1002\/14651858.CD003198-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/S0140-6736(75)90594-2","article-title":"Treatment of unipolar depression","volume":"2","author":"MacSweeney","year":"1975","journal-title":"Lancet"},{"issue":"0","key":"10.1002\/14651858.CD003198-BIB0044|cit44","first-page":"399","article-title":"The effect of L-5-Hydroxytryptophan alone and in combination with a decarboxylase inhibitor (Ro 4-4602) in depressive patients","volume":"11","author":"Matussek","year":"1974","journal-title":"Advances in Biochemical Psychopharmacology"},{"issue":"1-2","key":"10.1002\/14651858.CD003198-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/BF02245291","article-title":"Serotonergic function during lithium augmentation of refractory depression","volume":"108","author":"McCance-Katz","year":"1992","journal-title":"Psychopharmacology"},{"issue":"4","key":"10.1002\/14651858.CD003198-BIB0046|cit46","first-page":"162","article-title":"The effect of L-Tryptophan on seasonal affective disorder","volume":"51","author":"McGrath","year":"1990","journal-title":"Journal of Clinical Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD003198-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1001\/archpsyc.1984.01790150069010","article-title":"Effect of 5-Hydroxytryptophan on serum cortisol levels in major affective disorders II Relation to suicide","volume":"41","author":"Meltzer","year":"1984","journal-title":"Archives of General Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD003198-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1001\/archpsyc.1984.01790150081011","article-title":"Effect of 5-hydroxytryptophan on serum cortisol levels in major affective disorders. III. Effect of antidepressants and lithium carbonate","volume":"41","author":"Meltzer","year":"1984","journal-title":"Archives of General Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD003198-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1001\/archpsyc.1975.01760190024002","article-title":"Amine precursors and depression","volume":"32","author":"Mendels","year":"1975","journal-title":"Archives of General Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD003198-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0165-0327(80)90013-0","article-title":"Antidepressant potentiation of 5-Hydroxytryptophan by L-Deprenil in affective illness","volume":"2","author":"Mendlewicz","year":"1980","journal-title":"Journal of Affective Disorders"},{"issue":"1","key":"10.1002\/14651858.CD003198-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/BF00421216","article-title":"L-Tryptophan in affective disorders: Indoleamine changes and differential clinical effects","volume":"34","author":"Murphy","year":"1973","journal-title":"Psychopharmacologia"},{"key":"10.1002\/14651858.CD003198-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1192\/bjp.147.1.16","article-title":"L-5-HTP in depression resistant to reuptake inhibitors. An open comparative study with tranylcypromine","volume":"147","author":"Nolen","year":"1985","journal-title":"British Journal of Psychiatry"},{"issue":"1-2","key":"10.1002\/14651858.CD003198-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0278-5846(89)90012-2","article-title":"Tranylcypromine in depression resistant to cyclic antidepressions","volume":"13","author":"Nolen","year":"1989","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD003198-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/j.1600-0447.1988.tb06403.x","article-title":"Treatment strategy in depression II MAO inhibitors in depression resistant to cyclic antidepressants: two controlled crossover studies with tranylcypromine versus L-5-hydroxytryptophan and nomifensine","volume":"78","author":"Nolen","year":"1988","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"1-2","key":"10.1002\/14651858.CD003198-BIB0056|cit55","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0278-5846(89)90012-2","article-title":"Tranylcypromine in depression resistant to cyclic antidepressions","volume":"13","author":"Nolen","year":"1989","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD003198-BIB0055|cit56","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/j.1600-0447.1988.tb06403.x","article-title":"Treatment strategy in depression II MAO inhibitors in depression resistant to cyclic antidepressants: two controlled crossover studies with tranylcypromine versus L-5-hydroxytryptophan and nomifensine","volume":"78","author":"Nolen","year":"1988","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"2","key":"10.1002\/14651858.CD003198-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1159\/000284698","article-title":"A functional-dimensional approach to depression: Serotonin deficiency as a target syndrome in a comparison of 5-hydroxytryptophan and fluvoxamine","volume":"24","author":"Poldinger","year":"1991","journal-title":"Psychopathology"},{"issue":"1","key":"10.1002\/14651858.CD003198-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1001\/archpsyc.1974.01760070040006","article-title":"L-tryptophan in mania. Contribution to a permissive hypothesis of affective disorders","volume":"30","author":"Prange","year":"1974","journal-title":"Archives of General Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD003198-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0006-3223(97)00284-9","article-title":"The neurobiology of tryptophan depletion in depression: Effects of intravenous tryptophan infusion","volume":"43","author":"Price","year":"1998","journal-title":"Biological Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD003198-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000118063","article-title":"Comparison of the antidepressant action of tryptophan, tryptophan\/5-hydroxytryptophan combination and nomifensine","volume":"11","author":"Quadbeck","year":"1984","journal-title":"Neuropsychobiology"},{"key":"10.1002\/14651858.CD003198-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1136\/bmj.1.6007.460-b","article-title":"Tryptophan and depression","volume":"1","author":"Rao","year":"1976","journal-title":"BMJ"},{"issue":"3","key":"10.1002\/14651858.CD003198-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1600-0447.1978.tb06891.x","article-title":"Has tryptophan any anticonvulsive effect?","volume":"57","author":"Raotma","year":"1978","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"3","key":"10.1002\/14651858.CD003198-BIB0063|cit63","first-page":"267","article-title":"Effects of a levo-5-hydroxytryptophan-dihydroergocristine combination on depression and neuropsychic performance: a double blind, placebo controlled clinical trial in elderly patients","volume":"9","author":"Rousseau","year":"1987","journal-title":"Clinical Therapeutics"},{"key":"10.1002\/14651858.CD003198-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0165-0327(90)90003-Q","article-title":"Plasma tryptophan to large neutral amino acid ratios in depressed and normal subjects","volume":"19","author":"Russ","year":"1990","journal-title":"Journal of Affective Disorders"},{"issue":"12","key":"10.1002\/14651858.CD003198-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/0006-3223(94)90595-9","article-title":"Effects of sleep deprivation on serotonin function in depression","volume":"36","author":"Salomon","year":"1994","journal-title":"Biological Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD003198-BIB0066|cit66","first-page":"214","article-title":"Psychomotor skills in depressed outpatients treated with L-tryptophan, doxepin, or chlorimipramine","volume":"10","author":"Seppala","year":"1978","journal-title":"Annals of Clinical Research"},{"issue":"7656","key":"10.1002\/14651858.CD003198-BIB0067|cit67","first-page":"1111","article-title":"L-Tryptophan in depression","volume":"1","author":"Shaw","year":"1970","journal-title":"Lancet"},{"issue":"789","key":"10.1002\/14651858.CD003198-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0140-6736(72)92289-1","article-title":"Tricyclic antidepressants and tryptophan in unipolar affective disorder","volume":"2","author":"Shaw","year":"1972","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD003198-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1017\/S0033291700056646","article-title":"Tricyclic antidepressants and tryptophan in unipolar depression","volume":"5","author":"Shaw","year":"1975","journal-title":"Psychological Medicine"},{"issue":"5","key":"10.1002\/14651858.CD003198-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/j.1600-0447.1984.tb01236.x","article-title":"Lack of effect of tryptophan treatment in demented gerontopsychiatric patients: A double-blind, crossover-controlled study","volume":"70","author":"Smith","year":"1984","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"3","key":"10.1002\/14651858.CD003198-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0006-3223(98)00005-5","article-title":"A placebo-controlled clinical trial of L-tryptophan in premenstrual dysphoria","volume":"45","author":"Steinberg","year":"1999","journal-title":"Biological Psychiatry"},{"issue":"11","key":"10.1002\/14651858.CD003198-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1001\/archpsyc.1976.01770110112012","article-title":"Potentiation of the antidepressant action of clomipramine by tryptophan","volume":"33","author":"Walinder","year":"1976","journal-title":"Archives of General Psychiatry"},{"issue":"7913","key":"10.1002\/14651858.CD003198-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/S0140-6736(75)92052-8","article-title":"Potentiation of antidepressant action of clomipramine by tryptophan","volume":"1","author":"Walinder","year":"1975","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003198-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1192\/bjp.135.3.255","article-title":"Controlled studies of the acute antidepressant effects of lithium","volume":"135","author":"Worrall","year":"1979","journal-title":"British Journal of Psychiatry"},{"issue":"8","key":"10.1002\/14651858.CD003198-BIB0075|cit75","first-page":"646","article-title":"The indoleamine hypothesis of depression: An overview and pilot study","volume":"38","author":"Zarcone","year":"1977","journal-title":"Diseases of the Nervous System"},{"issue":"3","key":"10.1002\/14651858.CD003198-BIB0076|cit76","first-page":"256","article-title":"A self-body double blind clinical study of L-tryptophan and placebo in treated neurosis","volume":"10","author":"Zhao","year":"1989","journal-title":"Acta Academiae Medicinae Hubei"},{"key":"10.1002\/14651858.CD003198-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1055\/s-2007-1002225","article-title":"Serotonin precursors as an antidepressant: an overview.","volume":"51","author":"Beckmann","year":"1983","journal-title":"Fortschritte Neurologie und Psychiatrie"},{"issue":"6","key":"10.1002\/14651858.CD003198-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0049-0172(97)80022-4","article-title":"Eosinophilia myalgia syndrome","volume":"26","author":"Blackburn","year":"1997","journal-title":"Seminars in Arthritis and Rheumatism"},{"issue":"7572","key":"10.1002\/14651858.CD003198-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0140-6736(68)92459-8","article-title":"Noradrenaline, 5-hydroxytryptamine, and 5-hydroxyindoleacetic acid in hind brains of suicidal patients","volume":"II","author":"Bourne","year":"1968","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003198-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0140-6736(63)91084-5","article-title":"Potentiation of the antidepressive effect of a monoamine oxidase inhibitor by tryptophan","volume":"I","author":"Coppen","year":"1963","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD003198-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1600-0447.1978.tb06890.x","article-title":"L-tryptophan and 5-hydroxytryptophan in the treatment of depression, a review","volume":"57","author":"D'Elia","year":"1978","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"2","key":"10.1002\/14651858.CD003198-BIB0082|cit82","first-page":"175","article-title":"Depression - the commonest disease","volume":"106","author":"Edgell","year":"1972","journal-title":"Canadian Medical Association Journal"},{"issue":"1","key":"10.1002\/14651858.CD003198-BIB0083|cit83","first-page":"7","article-title":"Neurotransmitter precursors for the treatment of depression","volume":"18","author":"Gelenberg","year":"1982","journal-title":"Psychopharmacology Bulletin"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD003198-BIB0084|cit84","first-page":"81","article-title":"Bias or biology: evaluating the epidemiologic studies of L-tryptophan and the eosinophilia-myalgia syndrome","volume":"46","author":"Horowitz","year":"1996","journal-title":"Journal of Rheumatology"},{"issue":"8","key":"10.1002\/14651858.CD003198-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/BF00789141","article-title":"Belief systems of the general public concerning the appropriate treatments for mental disorders","volume":"32","author":"Jorm","year":"1997","journal-title":"Social Psychiatry & Psychiatric Epidemiology"},{"key":"10.1002\/14651858.CD003198-BIB0086|cit86","article-title":"Drug treatment in psychiatry - psychotropic drugs","volume-title":"Handbook of Biological Psychiatry","volume":"5","author":"Lader","year":"1981"},{"issue":"12","key":"10.1002\/14651858.CD003198-BIB0087|cit87","first-page":"2261","article-title":"An eosinophilia-myalgia syndrome related disorder associated with exposure to L-5-hydroxytryptophan","volume":"21","author":"Michelson","year":"1994","journal-title":"Journal of Rheumatology"},{"key":"10.1002\/14651858.CD003198-BIB0088|cit88","article-title":"Current status of the indolamine hypothesis of the affective disorders","volume-title":"Psychopharmacology: A generation of progress","author":"Murphy","year":"1978"},{"key":"10.1002\/14651858.CD003198-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1136\/jnnp.22.3.247","article-title":"Clinical and biochemical study of a trial of iproniazid in the treatment of depression","volume":"22","author":"Pare","year":"1959","journal-title":"Journal of neurology, Neurosurgery & Psychiatry"},{"issue":"7612","key":"10.1002\/14651858.CD003198-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0140-6736(69)92442-8","article-title":"5-hydroxytryptamine, noradrenaline, and dopamine in brainstem, hypothalamus, and caudate nucleus of controls and of patients committing suicide by coal-gas poisoning","volume":"II","author":"Pare","year":"1969","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD003198-BIB0091|cit91","first-page":"291","article-title":"Management of depression with serotonin precursors","volume":"16","author":"Praag","year":"1981","journal-title":"Biological Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD003198-BIB0092|cit92","first-page":"267","article-title":"Effects of a Levo-5-Hydroxytryptophan-Dihydroergocristine combination on depression and neuropsychic performance: A double-blind placebo-controlled clinical trial in elderly patients","volume":"9","author":"Rousseau","year":"1987","journal-title":"Clinical Therapeutics"},{"key":"10.1002\/14651858.CD003198-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1192\/bjp.113.505.1407","article-title":"5-Hydroxytryptamine in the hind brain of depressive suicides","volume":"113","author":"Shaw","year":"1963","journal-title":"British Journal of Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD003198-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1248\/cpb.39.820","article-title":"Characterization of contaminants in EMS-associated L-tryptophan samples by high-performance liquid chromatography","volume":"39","author":"Toyo'oka","year":"1991","journal-title":"Chemical and Pharmaceutical Bulletin"},{"key":"10.1002\/14651858.CD003198-BIB0095|cit95","article-title":"Selective serotonin reuptake inhibitors (SSRIs) for major depression: Part 1 Evaluation of the clinical literature","volume-title":"CCOHTA","author":"Trindade","year":"1997"},{"issue":"15","key":"10.1002\/14651858.CD003198-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/0006-2952(76)90400-7","article-title":"Control of brain neurotransmitter synthesis by precursor availability and nutritional state","volume":"25","author":"Wurtman","year":"1976","journal-title":"Biochemical Pharmacology"},{"issue":"4","key":"10.1002\/14651858.CD003198-BIB0097|cit97","first-page":"315","article-title":"Precursor control of neurotransmitter synthesis","volume":"32","author":"Wurtman","year":"1981","journal-title":"Pharmacological Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD003198\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T10:03:48Z","timestamp":1682589828000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD003198"}},"subtitle":[],"editor":[{"name":"Cochrane Common Mental Disorders Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2002,1,21]]},"references-count":97,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2010,1]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd003198","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,1,21]]}}}